Last update 22 May 2025

Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
CD19 x CD3ε
Action
modulators
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators), CD3ε modulators(CD3e molecule modulators)
Therapeutic Areas
Immune System DiseasesNervous System DiseasesCardiovascular Diseases+ [6]
Active Indication
Antiphospholipid SyndromeChurg-Strauss SyndromeDermatomyositis+ [5]
Inactive Indication-
Originator Organization
Shanghai Changzheng Hospital
Active Organization
Shanghai Changzheng Hospital
Inactive Organization-
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
NCT06373081
/ RecruitingNot ApplicableIIT
A Clinical Study on the Safety and Efficacy of Anti-CD19-CD3E-CAR-T Cells in the Treatment of Relapsed or Refractory Autoimmune Disease
100 Clinical Results associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
Login to view more data
100 Translational Medicine associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
Login to view more data
100 Patents (Medical) associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
Login to view more data
100 Deals associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Antiphospholipid SyndromeClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
Churg-Strauss SyndromeClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
DermatomyositisClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
Granulomatosis With PolyangiitisClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
Microscopic PolyangiitisClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
Primary Sjögren's syndromeClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
Scleroderma, DiffuseClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
Systemic Lupus ErythematosusClinical
China
Shanghai Changzheng Hospital
20 Apr 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free